NEWARK, Del: The global Hyaluronic Viscosupplementation Market is expected to reach US$ 4.0 billion by 2033, from US$ 2.3 billion in 2022. With a value share of around 49.1%, three injection knee hyaluronic acid injections topped the global Market within the product category in 2022 and is expected to grow at a CAGR of close to 5.2% over the forecast period (2023 to 2033).
The hyaluronic viscosupplementation market has experienced significant growth and innovation in recent years. Viscosupplementation involves the injection of hyaluronic acid, a natural component of synovial fluid in joints, to alleviate pain and improve mobility in individuals suffering from osteoarthritis, particularly in the knee. This minimally invasive procedure has gained popularity as an alternative to more invasive surgical options, driving market expansion. Factors such as the aging global population, the increasing prevalence of osteoarthritis, and a growing emphasis on non-surgical treatments for joint pain have contributed to the market’s growth.
Request to Download Sample Summary Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-17713
The World Health Organization highlights osteoarthritis (OA) as a significant contributor to functional disability in older adults, affecting 9.6% of men and 18% of women aged over 60 years.
Viscosupplements, containing hyaluronic acid, are being used to improve viscoelasticity, reduce symptoms, and enhance joint functionality. These molecules are incorporated with anti-inflammatory drugs to improve short-term pain relief and enhance the bioactive principle at the injured cartilage site. Combining viscosupplements with regenerative therapies is promising for stimulating intrinsic cartilage repair and regeneration. The cost of treatment is minimal and affordable for all sections of patients.
In general, the market for Hyaluronic Viscosupplementation Market Share is likely to expand more in the coming years. This market provides people with a cheaper and more convenient way to improve their joint condition.
Key Takeaways from the Market Study:
- By product, three injection knee hyaluronic acid injection accounts for US$ 1.14 billion in 2022 owing to the benefits provided in knee osteoarthritis pain.
- By indication, knee osteoarthritis accounts for US$ 2.0 Billion in 2022. Knee osteoarthritis (OA) is a prominent joint disease affecting the quality of life and socioeconomic impact, causing job losses. It affects more than 40% of adults globally and leads to poor or fair health, affecting non-institutionalized adults.
- By molecular weight, high molecular weight hyaluronic viscosupplementation contributed around US$ 1.6 Billion in 2022. Due to the high polymer chain it easily enters tissue and has better activity anti-inflammatory activity than low molecular weight hyaluronate.
- By body part, Knee held more than 85.0% of the global market share in 2022. As knees are most commonly affected by osteoarthritis-like conditions as one grows older, viscosupplementation in knee osteoarthritis treatments may offer cost-effectiveness and delay total arthroplasty.
- Hospitals and ambulatory surgical centers together held more than 55.0% of the global market share in 2022. This can be ascribed to the fact that the prominent of the world’s population suffers from diseases and obesity, which can be adequately identified in these settings with qualified assistance.
- By region, North America held the dominant share in the world in 2022. The U.S. leads in this region with a high prevalence of osteoarthritis and a high requirement of viscosupplementation therapy.
Hyaluronic Viscosupplementation Market Research Report Coverage:
| Attributes | Details |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2012 to 2022 |
| Market Analysis | US$ Million for Value, Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa (MEA) |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, United Kingdom, Spain, BENELUX, Russia, Nordics, China, Japan, South Korea, India, Indonesia, Thailand, Philippines, Malaysia, Australia, New Zealand, GCC countries, Türkiye, Israel, Northern Africa and South Africa. |
| Key Market Segments Covered | Product, Body Part, Molecular Weight, Indication, End User, and Region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Discover the Path to Optimal Health! Dive Deep into Hyaluronic Viscosupplementation Market Analysis with Exclusive Discounts: https://www.futuremarketinsights.com/checkout/17713
Market Competition:
The hyaluronic viscosupplementation market is highly competitive, with key players including Anika Therapeutics and Seikagaku. These companies are constantly participating in conferences, and award competitions with their products and launching new products to gain a larger market share, with a focus on affordability, convenience, and effectiveness.
- In July 2022, Anika Therapeutics wins ACE Award for Tactoset, a biocompatible, easily injectable, and interdigitating bone graft substitute in Sports Medicine, enhancing hardware augmentation.
- In August 2021, Seikagaku launched HyLink® for knee osteoarthritis treatment in Taiwan.
Hyaluronic Viscosupplementation Market Segmentation:
By Product:
- Single Injection Knee Hyaluronic Acid Injections
- Three Injection Knee Hyaluronic Acid Injections
- Five Injection Knee Hyaluronic Acid Injections
- Next Generation (Steroid Combination)
By Body Parts:
- Knee
- Hip
- Shoulder
- Small Joints
- Others
By Molecular Weight:
- High Molecular Weight
- Medium Molecular Weight
- Low Molecular Weight
By Indication:
- Knee Osteoarthritis
- Tendinopathies
- Shoulder Arthritis
- Hip Osteoarthritis
- Frozen Shoulder
- Ligament Injury
- Post-Arthroscopy
- Others
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Orthopaedic Clinics
- Retail Pharmacies
- Online Sales
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa
Explore Future Market Insights, Inc. Extensive Coverage in Healthcare Market Domain:
Healthcare Interoperability Solutions Market Analysis: The global healthcare interoperability solutions market is forecasted to expand at 14.5% CAGR to reach a market valuation of US$ 16.2 billion by the end of 2033, up from US$ 3.7 billion which was recorded for 2022.
Healthcare Regulatory Affairs Outsourcing Market Sales: The healthcare regulatory affairs outsourcing market is expected to grow at a CAGR of 11.3% during the forecast period. The market is valued at US$ 2 billion as of 2023, and by 2033, the market is expected to hit a valuation of US$ 5.8 billion.
Healthcare IT Outsourcing Market Outlook: The healthcare IT outsourcing market trend is projected to record a robust CAGR of 7.2% between 2023 and 2033, totaling around US$ 105.753 billion by the end of 2033.
About Future Market Insights (FMI):
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization, and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn | Twitter | Blogs | YouTube
The post Hyaluronic Viscosupplementation Rise towards a US$ 4 Billion Global Market by 2033: Easing Osteoarthritis Struggles | Future Market Insights appeared first on Future Market Insights.
Published by: Future Market Insights, Inc.